ATAZANAVIR AND COBICISTAT

ATAZANAVIR AND COBICISTAT was reported 245 times

ATAZANAVIR AND COBICISTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSIENT NEONATAL PUSTULAR MELANOSIS 3 0.3750
1 INVOLUNTARY COMMITMENT 1 0.0833
2 TRISOMY 15 1 0.0588
3 CONGENITAL MELANOCYTIC NAEVUS 2 0.0444
4 PREGNANCY WITH ADVANCED MATERNAL AGE 1 0.0208
5 CREUTZFELDT-JAKOB DISEASE 5 0.0173
6 ISCHAEMIC SKIN ULCER 1 0.0108
7 MELANOSIS 1 0.0089
8 PLACENTA PRAEVIA 6 0.0076
9 CONGENITAL NAEVUS 1 0.0070
10 BONE DEMINERALISATION 6 0.0057
11 POLYHYDRAMNIOS 5 0.0049
12 HAEMOPHILIA 1 0.0047
13 SPINA BIFIDA 9 0.0043
14 BLOOD BILIRUBIN UNCONJUGATED INCREASED 3 0.0041
15 RENAL TUBULAR DYSFUNCTION 2 0.0035
16 CONGENITAL CHOROID PLEXUS CYST 1 0.0033
17 BONE MARROW TOXICITY 3 0.0025
18 OSTEOMALACIA 3 0.0019
19 LIPODYSTROPHY ACQUIRED 4 0.0019
20 BODY FAT DISORDER 1 0.0018
21 ANENCEPHALY 1 0.0018
22 COLLAGEN DISORDER 1 0.0017
23 HYPERBILIRUBINAEMIA NEONATAL 1 0.0017
24 BLOOD HIV RNA INCREASED 3 0.0017
25 PROTEIN TOTAL ABNORMAL 2 0.0015
26 HEAD AND NECK CANCER 1 0.0015
27 ALCOHOL INTOLERANCE 1 0.0014
28 ANHEDONIA 36 0.0014
29 VIRAL MUTATION IDENTIFIED 5 0.0014
30 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
31 OSTEOPENIA 18 0.0012
32 ENZYME LEVEL INCREASED 1 0.0012
33 FANCONI SYNDROME ACQUIRED 2 0.0011
34 PARTNER STRESS 1 0.0010
35 MUCOSAL ULCERATION 1 0.0010
36 HYPERBILIRUBINAEMIA 10 0.0010
37 HYPERTENSIVE NEPHROPATHY 1 0.0009
38 PRODUCT NAME CONFUSION 1 0.0009
39 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
40 ECONOMIC PROBLEM 13 0.0009
41 GASTROINTESTINAL TUBE INSERTION 2 0.0008
42 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
43 CATAPLEXY 1 0.0007
44 FIBULA FRACTURE 2 0.0007
45 OCULAR ICTERUS 3 0.0007
46 FAT TISSUE INCREASED 1 0.0007
47 ECTOPIC PREGNANCY 2 0.0006
48 TRANSCRIPTION MEDICATION ERROR 1 0.0006
49 ABORTION INDUCED 6 0.0006
50 SHOULDER FRACTURE 1 0.0006
51 OSTEOPOROSIS 25 0.0006
52 BONE DENSITY DECREASED 18 0.0006
53 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
54 PATHOGEN RESISTANCE 5 0.0005
55 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
56 NARCOLEPSY 1 0.0005
57 RHEUMATIC DISORDER 1 0.0005
58 LIVE BIRTH 4 0.0005
59 BLOOD TESTOSTERONE INCREASED 1 0.0005
60 DECREASED ACTIVITY 5 0.0005
61 RENAL TUBULAR ACIDOSIS 1 0.0005
62 TIBIA FRACTURE 2 0.0004
63 PUSTULE 1 0.0004
64 HYPERPARATHYROIDISM SECONDARY 1 0.0004
65 EXCORIATION 1 0.0004
66 FOETAL DEATH 2 0.0004
67 EXFOLIATIVE RASH 1 0.0004
68 CHONDROPATHY 1 0.0004
69 MULTIPLE FRACTURES 6 0.0004
70 RENAL TUBULAR DISORDER 1 0.0004
71 HIV INFECTION 1 0.0003
72 EMOTIONAL DISTRESS 40 0.0003
73 CRANIOCEREBRAL INJURY 1 0.0003
74 FOREIGN BODY IN THROAT 1 0.0003
75 PRODUCT PREPARATION ISSUE 2 0.0003
76 QUALITY OF LIFE DECREASED 4 0.0003
77 TONGUE ULCERATION 1 0.0003
78 SKELETAL INJURY 3 0.0003
79 HAEMORRHAGIC DIATHESIS 1 0.0003
80 CHRONIC KIDNEY DISEASE 21 0.0003
81 END STAGE RENAL DISEASE 5 0.0003
82 HYPOPHOSPHATAEMIA 2 0.0003
83 BONE LOSS 4 0.0003
84 AUTOIMMUNE THYROIDITIS 1 0.0003
85 OESOPHAGEAL DISORDER 1 0.0003
86 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
87 LOW BIRTH WEIGHT BABY 2 0.0003
88 SPINAL FUSION SURGERY 1 0.0002
89 DRUG RESISTANCE 6 0.0002
90 DIVERTICULUM INTESTINAL 1 0.0002
91 BLOOD CREATINE INCREASED 1 0.0002
92 LUMBAR VERTEBRAL FRACTURE 1 0.0002
93 NEPHROGENIC ANAEMIA 1 0.0002
94 PROTEINURIA 4 0.0002
95 PROTEIN URINE PRESENT 1 0.0002
96 ABORTION SPONTANEOUS 8 0.0002
97 EMPHYSEMA 2 0.0002
98 TOE AMPUTATION 1 0.0002
99 ANKLE FRACTURE 3 0.0002
100 RENAL PAIN 2 0.0002
101 PREMATURE DELIVERY 3 0.0002
102 STRESS FRACTURE 1 0.0002
103 BLOOD BILIRUBIN INCREASED 5 0.0002
104 BACK INJURY 2 0.0002
105 NECROSIS 1 0.0002
106 VENTRICULAR SEPTAL DEFECT 1 0.0002
107 MOUTH SWELLING 1 0.0002
108 METABOLIC DISORDER 1 0.0002
109 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
110 TENSION 1 0.0002
111 EXPOSURE DURING PREGNANCY 10 0.0002
112 PRE-EXISTING CONDITION IMPROVED 1 0.0002
113 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
114 CORONAVIRUS INFECTION 1 0.0002
115 MENSTRUATION IRREGULAR 4 0.0001
116 POST-TRAUMATIC STRESS DISORDER 1 0.0001
117 RIB FRACTURE 3 0.0001
118 TOOTH LOSS 3 0.0001
119 HAND FRACTURE 1 0.0001
120 PANIC REACTION 1 0.0001
121 BLOOD CREATININE INCREASED 9 0.0001
122 ANXIETY 39 0.0001
123 TORSADE DE POINTES 1 0.0001
124 DRUG SCREEN POSITIVE 1 0.0001
125 SENSORY LOSS 1 0.0001
126 OSTEONECROSIS 4 0.0001
127 SPINAL COMPRESSION FRACTURE 1 0.0001
128 RENAL IMPAIRMENT 10 0.0001
129 SKIN HYPERPIGMENTATION 1 0.0001
130 GRIP STRENGTH DECREASED 1 0.0001
131 RENAL FAILURE 15 0.0001
132 JAUNDICE 3 0.0001
133 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
134 ERYTHEMA MULTIFORME 1 0.0001
135 NEPHROPATHY 1 0.0001
136 FRACTURE 2 0.0001
137 SPINAL DISORDER 1 0.0001
138 DYSSTASIA 3 0.0001
139 THERAPY CHANGE 1 0.0001
140 SPINAL FRACTURE 2 0.0001
141 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
142 METABOLIC ACIDOSIS 3 0.0001
143 HIP FRACTURE 3 0.0001
144 BIPOLAR DISORDER 1 0.0001
145 DENTAL CARIES 1 0.0001
146 STATUS EPILEPTICUS 1 0.0001
147 RENAL DISORDER 4 0.0001
148 MUSCLE ATROPHY 1 0.0001
149 HEPATITIS 2 0.0001
150 HIATUS HERNIA 1 0.0001
151 BEDRIDDEN 1 0.0001
152 FEAR 2 0.0001
153 PERIPHERAL COLDNESS 1 0.0001
154 OSTEOARTHRITIS 3 0.0001
155 INTENTIONAL DOSE OMISSION 2 0.0001
156 PAIN 43 0.0001
157 IMPAIRED QUALITY OF LIFE 1 0.0001
158 RENAL INJURY 2 0.0001
159 HIP ARTHROPLASTY 1 0.0001
160 ADVERSE EVENT 6 0.0001
161 FEMUR FRACTURE 2 0.0001
162 BLOOD CHOLESTEROL INCREASED 3 0.0001
163 DRUG LEVEL INCREASED 1 0.0001
164 BLOOD UREA INCREASED 1 0.0001
165 GAIT DISTURBANCE 11 0.0001
166 ECZEMA 3 0.0001
167 DEPRESSION 13 0.0001
168 DRUG INTERACTION 9 0.0001
169 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
170 HEAD DISCOMFORT 1 0.0001
171 HEPATIC STEATOSIS 1 0.0001
172 BACTERIAL INFECTION 1 0.0001
173 MIDDLE INSOMNIA 1 0.0001
174 FOOT FRACTURE 1 0.0001
175 SLEEP APNOEA SYNDROME 1 0.0001
176 LOWER LIMB FRACTURE 1 0.0001
177 ACUTE RESPIRATORY FAILURE 1 0.0001
178 DISABILITY 1 0.0001
179 RHABDOMYOLYSIS 2 0.0000
180 POLLAKIURIA 2 0.0000
181 MOUTH ULCERATION 1 0.0000
182 IMPAIRED WORK ABILITY 1 0.0000
183 IRRITABLE BOWEL SYNDROME 1 0.0000
184 STEVENS-JOHNSON SYNDROME 1 0.0000
185 RASH MACULO-PAPULAR 1 0.0000
186 ACUTE KIDNEY INJURY 6 0.0000
187 ERECTILE DYSFUNCTION 1 0.0000
188 DIPLOPIA 1 0.0000
189 SEDATION 1 0.0000
190 PALLOR 1 0.0000
191 CARDIAC ARREST 3 0.0000
192 ABNORMAL DREAMS 1 0.0000
193 DIVERTICULITIS 1 0.0000
194 ARTHROPATHY 2 0.0000
195 PRODUCT STORAGE ERROR 3 0.0000
196 BLOOD POTASSIUM DECREASED 1 0.0000
197 PREMATURE BABY 1 0.0000
198 THERAPEUTIC RESPONSE DECREASED 2 0.0000
199 LIMB DISCOMFORT 1 0.0000
200 LIP SWELLING 1 0.0000
201 HEPATIC ENZYME INCREASED 2 0.0000
202 HAEMATURIA 1 0.0000
203 GASTRIC DISORDER 1 0.0000
204 ILLNESS 3 0.0000
205 THERAPY INTERRUPTED 2 0.0000
206 MOBILITY DECREASED 2 0.0000
207 PANIC ATTACK 1 0.0000
208 INJECTION SITE MASS 1 0.0000
209 BRONCHITIS 2 0.0000
210 BACK PAIN 6 0.0000
211 PALPITATIONS 3 0.0000
212 ARTHRITIS 2 0.0000
213 LUNG NEOPLASM MALIGNANT 1 0.0000
214 CARDIO-RESPIRATORY ARREST 1 0.0000
215 ANGIOEDEMA 1 0.0000
216 LIVER DISORDER 1 0.0000
217 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
218 VISION BLURRED 3 0.0000
219 SKIN DISCOLOURATION 1 0.0000
220 ARRHYTHMIA 1 0.0000
221 DYSPHAGIA 2 0.0000
222 COMA 1 0.0000
223 DRUG INTOLERANCE 2 0.0000
224 HYPOGLYCAEMIA 1 0.0000
225 DYSPEPSIA 2 0.0000
226 HEART RATE INCREASED 2 0.0000
227 SINUSITIS 2 0.0000
228 THERAPY CESSATION 1 0.0000
229 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
230 ABDOMINAL DISTENSION 2 0.0000
231 RASH PRURITIC 1 0.0000
232 TREATMENT NONCOMPLIANCE 1 0.0000
233 NECK PAIN 1 0.0000
234 FLATULENCE 1 0.0000
235 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
236 SURGERY 1 0.0000
237 IRRITABILITY 1 0.0000
238 NO ADVERSE EVENT 3 0.0000
239 ASTHENIA 6 0.0000
240 ANAEMIA 3 0.0000
241 SWELLING FACE 1 0.0000
242 INSOMNIA 4 0.0000
243 INJECTION SITE PRURITUS 1 0.0000
244 MEMORY IMPAIRMENT 2 0.0000
245 INJURY 1 0.0000
246 SLEEP DISORDER 1 0.0000
247 AGITATION 1 0.0000
248 DYSGEUSIA 1 0.0000
249 WEIGHT INCREASED 3 0.0000
250 UNEVALUABLE EVENT 1 0.0000
251 CONDITION AGGRAVATED 4 0.0000
252 MYALGIA 2 0.0000
253 MUSCULOSKELETAL STIFFNESS 1 0.0000
254 TACHYCARDIA 1 0.0000
255 NEUROPATHY PERIPHERAL 1 0.0000
256 DEATH 9 0.0000
257 CONTUSION 1 0.0000
258 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
259 CHEST DISCOMFORT 1 0.0000
260 PLATELET COUNT DECREASED 1 0.0000
261 RASH 4 0.0000
262 INFLUENZA 1 0.0000
263 SEPSIS 1 0.0000
264 INCORRECT DOSE ADMINISTERED 2 0.0000
265 DECREASED APPETITE 2 0.0000
266 FEELING ABNORMAL 2 0.0000
267 OEDEMA PERIPHERAL 1 0.0000
268 VISUAL IMPAIRMENT 1 0.0000
269 INJECTION SITE ERYTHEMA 1 0.0000
270 DIZZINESS 4 0.0000
271 NAUSEA 6 0.0000
272 ARTHRALGIA 3 0.0000
273 WEIGHT DECREASED 2 0.0000
274 MALAISE 3 0.0000
275 PAIN IN EXTREMITY 2 0.0000
276 HYPOAESTHESIA 1 0.0000
277 BLOOD PRESSURE INCREASED 1 0.0000
278 HOSPITALISATION 1 0.0000
279 PERIPHERAL SWELLING 1 0.0000
280 FATIGUE 5 0.0000
281 DRUG DOSE OMISSION 1 0.0000
282 TREMOR 1 0.0000
283 MYOCARDIAL INFARCTION 1 0.0000
284 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
285 HYPERSENSITIVITY 1 0.0000
286 PRODUCT USE ISSUE 1 0.0000
287 PRURITUS 2 0.0000
288 SOMNOLENCE 1 0.0000
289 ABDOMINAL PAIN UPPER 1 0.0000
290 HEADACHE 3 0.0000
291 HYPERTENSION 1 0.0000
292 OVERDOSE 1 0.0000
293 CONSTIPATION 1 0.0000
294 DYSPNOEA 2 0.0000
295 PRODUCT DOSE OMISSION ISSUE 1 0.0000
296 FALL 1 0.0000
297 PYREXIA 1 0.0000
298 DRUG INEFFECTIVE 3 0.0000
299 VOMITING 1 0.0000
300 DIARRHOEA 1 0.0000
301 OFF LABEL USE 1 0.0000